<div id="readability-page-1"><div><p><span>Lin Sue-Jean Director of Arcutis Biotherapeutics Inc [ARQT] filed a Form 4 on November 25, 2025 with the Securities and Exchange Commission disclosing the following changes in ownership:</span></p><div><table><tbody><tr><th><span>Date</span></th><th><span>Transaction</span></th><th><span>Shares</span></th><th><span>Price</span></th><th><span>Value</span></th></tr><tr><td><span>11/24/25</span></td><td><span>Exercise(1)</span></td><td><span>25,272</span></td><td><span>$8.31</span></td><td><span>$210,010</span></td></tr><tr><td><span>11/24/25</span></td><td><span>Sale</span></td><td><span>25,272</span></td><td><span>$30.78</span></td><td><span>$777,956</span></td></tr></tbody></table></div><p><span>Ending Holdings: 26,735 - Direct</span></p><div><table><tbody><tr><td><span>(1)</span></td><td><span>18,052 shares exercised 8.6 years before expiration date.</span></td></tr><tr><td><span> </span></td><td><span>7,220 shares exercised 7.5 years before expiration date.</span></td></tr></tbody></table></div><p><span>For a free trial, or to learn more about our insider trading analysis and data services, please visit http://www.washingtonservice.com or contact us at (301) 913-5100 or send an email to info@washingtonservice.com.</span></p><p><span>Founded in 1970, The Washington Service provides securities professionals with financial, economic and public policy research and data.</span></p><span> </span></div></div>

ARQT

<p>Lin Sue-Jean, Director of Arcutis Biotherapeutics Inc [ARQT], sold 25,272 shares worth $778K on November 24, 2025. The shares were sold at $30.78 each. Lin also exercised 25,272 shares at $8.31 each. Ending holdings are 26,735 shares. The transaction was disclosed in a Form 4 filed with the SEC.</p>

Dir Lin Sells 25,272 ($778K) Of Arcutis Biotherapeutics Inc [ARQT]